Consensus ESG Ratings
Member Sign In
ESG News For ZHEJIANG AISHIDA ELECTRIC CO., LTD.
These sites contributed news to this page:
-
UBS Celebrates 16th Year as Presenting Sponsor of Art San Diego and Continues Philanthropic Access to Art Program Benefitting Monarch School Students
The three-day contemporary art event welcomes 10,000+ attendees to San Diego Convention Center, November 1-3, 2024Partnership with Redwood Art Group, Monarch School, Humble Design and ARTS DISTRICT Liberty Station furthers UBS’s commitment to supporting and encouraging local artistic communities, while benefitting underserved families and childrenThe US art market continues to lead in global rankings of art sales worldwide according to the Global Art Market Report published by UBS and Art Basel -
GoMacro® Announces New Annual Give Back Partnerships Promoting Autism Advocacy
A portion of net proceeds from March sales of all Kids MacroBars® will be donated to Autism Society of America and Autism Tree. -
Mahalo Banking Neurodiversity Platform Wows at NACUSO’s Next Big Idea Competition
Neurodiversity platform functionality takes second place in credit union banking innovation competition, awarded prize winnings of $2,500 -
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
STALICLA will be a leading contributor to the Euro-Global Platform for Mechanism-based Drug Repurposing (REPO4EU) consortium, with a EUR 1.7 million budget allocated to STALICLA Discovery and Data Science (DDS) unit -
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
Clinical data clear major test for the first precision neurodevelopmental disorders discovery platform, with a first application in Autism Spectrum Disorder (ASD) -
Northern Trust Obtains Hard-to-Find Technical Talent for Business Intelligence Analysis & Decision Making with CAI’s Autism2Work Program
Autism-focused national disability-inclusive employment initiative increases workplace productivity. -
STALICLA Translates its Novel Precision Medicine Approach for Autism Spectrum Disorder into Clinical Development with First Patient in Phase 1b Trial of STP1
-First precision therapeutic to be investigated in a biologically defined ASD subpopulation: ASD-Phen1 discovered and clinically validated by STALICLA--STP1 could provide a new therapeutic option for as many as 20% of patients with non-monogenetic causes of ASD- -
Florida Community Bank Rallies Statewide in Support of National Autism Awareness Month
Florida Community Bank Rallies Statewide in Support of National Autism Awareness Month -
Vivint Smart Home Unveils New Sensory Environment at Vivint Smart Home Arena to Support Children With Intellectual and Developmental Disabilities
In honor of Autism Awareness Month, Vivint also launches smart home giveaway for families affected by autism spectrum disorder